73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
2023 cisplatin shortage tied to use of alternatives for head, neck cancer

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente
Can physical exercise enhance the effect of chemotherapy against breast cancer?

Can physical exercise enhance the effect of chemotherapy against breast cancer?

byKarolinska InstitutetSchematic presentation of published evidence regarding physical activity and breast cancer. Credit:PLOS ONE(2022). DOI: 10.1371/journal.pone.0274804Approximate

Can physical exercise enhance the effect of chemotherapy against breast cancer?

byKarolinska InstitutetSchematic presentation of published evidence regarding physical activity and breast cancer. Credit:PLOS ONE(2022). DOI: 10.1371/journal.pone.0274804Approximate
Researchers identify needs of rural-based physicians to optimize cancer survivorship care

Researchers identify needs of rural-based physicians to optimize cancer survivorship care

by University of MissouriCredit: Unsplash/CC0 Public DomainThe vast majority of cancer survivors rely on primary care clinicians for follow-up treatments, especially in rural areas, according to

Researchers identify needs of rural-based physicians to optimize cancer survivorship care

by University of MissouriCredit: Unsplash/CC0 Public DomainThe vast majority of cancer survivors rely on primary care clinicians for follow-up treatments, especially in rural areas, according to
Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

by University of GothenburgThe researchers’ molecule Z4P inhibits one of the mechanisms that regulate protein production in a cancer cell. This inhibition causes the cancer cell to die. Three pic

Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

by University of GothenburgThe researchers’ molecule Z4P inhibits one of the mechanisms that regulate protein production in a cancer cell. This inhibition causes the cancer cell to die. Three pic
A 'dirty bomb' battles cancer metastasis

A 'dirty bomb' battles cancer metastasis

by Northwestern UniversityMetarrestin treatment markedly reduced the number of metastatic tumors in the liver and lung of mice with pancreatic cancer. Credit: K.J. Frankowski et al., Science Translati

A 'dirty bomb' battles cancer metastasis

by Northwestern UniversityMetarrestin treatment markedly reduced the number of metastatic tumors in the liver and lung of mice with pancreatic cancer. Credit: K.J. Frankowski et al., Science Translati
Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

by Institute for Research in Biomedicine (IRB Barcelona)Differences between tumours in male and female vinegar flies. Credit: Cayetano González, IRB BarcelonaAn understanding of the molecular bas

Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

by Institute for Research in Biomedicine (IRB Barcelona)Differences between tumours in male and female vinegar flies. Credit: Cayetano González, IRB BarcelonaAn understanding of the molecular bas
Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l
Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice

Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice

by Hadley Leggett,Stanford University Medical CenterCredit: AI-generated imageWhile studying a type of bacteria that lives on the healthy skin of every human being, researchers from Stanford Med

Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice

by Hadley Leggett,Stanford University Medical CenterCredit: AI-generated imageWhile studying a type of bacteria that lives on the healthy skin of every human being, researchers from Stanford Med
Testing method could point thousands more cancer patients to lifesaving treatment

Testing method could point thousands more cancer patients to lifesaving treatment

byUniversity of OklahomaDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHNot all cancer therapies are successful, but cancer researchers increa

Testing method could point thousands more cancer patients to lifesaving treatment

byUniversity of OklahomaDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHNot all cancer therapies are successful, but cancer researchers increa
Tumors form temporary structures to avoid immunotherapy treatments

Tumors form temporary structures to avoid immunotherapy treatments

byeLifeTumor-reactive T cells induce transient cell-in-cell structure. (A) Mean percentage of cell-in-cell tumor formations following incubation of B16F10 cells with immune cells (n=4). (B) Repr

Tumors form temporary structures to avoid immunotherapy treatments

byeLifeTumor-reactive T cells induce transient cell-in-cell structure. (A) Mean percentage of cell-in-cell tumor formations following incubation of B16F10 cells with immune cells (n=4). (B) Repr
Tumors backfire on chemotherapy

Tumors backfire on chemotherapy

by Ecole Polytechnique Federale de LausanneEndothelial cells (blue/grey) internalizing exosomes (red) released from chemotherapy-treated tumors. Credit: C. Cianciaruso/I. Keklikoglou/EPFLSome pat

Tumors backfire on chemotherapy

by Ecole Polytechnique Federale de LausanneEndothelial cells (blue/grey) internalizing exosomes (red) released from chemotherapy-treated tumors. Credit: C. Cianciaruso/I. Keklikoglou/EPFLSome pat
New model could reduce reliance on chemotherapy

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast